Xu YC - Search Results

1

Anti-inflammatory signaling through G protein-coupled receptors.

Ge YJ, Liao QW, Xu YC, Zhao Q, Wu BL, Ye RD. Ge YJ, et al. Among authors: xu yc. Acta Pharmacol Sin. 2020 Dec;41(12):1531-1538. doi: 10.1038/s41401-020-00523-1. Epub 2020 Oct 15. Acta Pharmacol Sin. 2020. PMID: 33060777 Free PMC article. Review.

2

Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.

Shen J, Zhang L, Song WL, Meng T, Wang X, Chen L, Feng LY, Xu YC, Shen JK. Shen J, et al. Among authors: xu yc. Acta Pharmacol Sin. 2013 Mar;34(3):441-52. doi: 10.1038/aps.2012.151. Epub 2013 Jan 21. Acta Pharmacol Sin. 2013. PMID: 23334237 Free PMC article.

3

Microsecond molecular dynamics simulation of Aβ42 and identification of a novel dual inhibitor of Aβ42 aggregation and BACE1 activity.

Wang YY, Li L, Chen TT, Chen WY, Xu YC. Wang YY, et al. Among authors: xu yc. Acta Pharmacol Sin. 2013 Sep;34(9):1243-50. doi: 10.1038/aps.2013.55. Epub 2013 Jun 17. Acta Pharmacol Sin. 2013. PMID: 23770985 Free PMC article.

4

Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor.

Zhong M, Song WL, Xu YC, Ye Y, Feng LY. Zhong M, et al. Among authors: xu yc. Acta Pharmacol Sin. 2015 Mar;36(3):298-310. doi: 10.1038/aps.2014.154. Epub 2015 Feb 9. Acta Pharmacol Sin. 2015. PMID: 25661317 Free PMC article.

5

Biochemical features of the adhesion G protein-coupled receptor CD97 related to its auto-proteolysis and HeLa cell attachment activities.

Yang LY, Liu XF, Yang Y, Yang LL, Liu KW, Tang YB, Zhang M, Tan MJ, Cheng SM, Xu YC, Yang HY, Liu ZJ, Song GJ, Huang W. Yang LY, et al. Among authors: xu yc. Acta Pharmacol Sin. 2017 Jan;38(1):56-68. doi: 10.1038/aps.2016.89. Epub 2016 Sep 19. Acta Pharmacol Sin. 2017. PMID: 27641734 Free PMC article.

6

Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.

Chen YT, Chen WY, Huang XT, Xu YC, Zhang HY. Chen YT, et al. Among authors: xu yc. Acta Pharmacol Sin. 2018 Feb;39(2):177-183. doi: 10.1038/aps.2017.113. Epub 2017 Aug 24. Acta Pharmacol Sin. 2018. PMID: 28836584 Free PMC article.

7

Structural basis for ligand recognition of the human thromboxane A₂ receptor.

Fan H, Chen S, Yuan X, Han S, Zhang H, Xia W, Xu Y, Zhao Q, Wu B. Fan H, et al. Nat Chem Biol. 2019 Jan;15(1):27-33. doi: 10.1038/s41589-018-0170-9. Epub 2018 Dec 3. Nat Chem Biol. 2019. PMID: 30510189

8

Structural basis of ligand binding modes at the human formyl peptide receptor 2.

Chen T, Xiong M, Zong X, Ge Y, Zhang H, Wang M, Won Han G, Yi C, Ma L, Ye RD, Xu Y, Zhao Q, Wu B. Chen T, et al. Nat Commun. 2020 Mar 5;11(1):1208. doi: 10.1038/s41467-020-15009-1. Nat Commun. 2020. PMID: 32139677 Free PMC article.

9

Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor.

Tian QQ, Zhu YT, Diao XX, Zhang XL, Xu YC, Jiang XR, Shen JS, Wang Z, Zhong DF. Tian QQ, et al. Among authors: xu yc. Acta Pharmacol Sin. 2021 Mar;42(3):482-490. doi: 10.1038/s41401-020-0447-x. Epub 2020 Jun 24. Acta Pharmacol Sin. 2021. PMID: 32581257 Free PMC article.

10

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.

Su HX, Yao S, Zhao WF, Li MJ, Liu J, Shang WJ, Xie H, Ke CQ, Hu HC, Gao MN, Yu KQ, Liu H, Shen JS, Tang W, Zhang LK, Xiao GF, Ni L, Wang DW, Zuo JP, Jiang HL, Bai F, Wu Y, Ye Y, Xu YC. Su HX, et al. Among authors: xu yc. Acta Pharmacol Sin. 2020 Sep;41(9):1167-1177. doi: 10.1038/s41401-020-0483-6. Epub 2020 Jul 31. Acta Pharmacol Sin. 2020. PMID: 32737471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

752 results

Search Page